A novel missense mutation (N78D) in a family with von Hippel–Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts - S. Cingoz; R. B. van der Luijt; E. Kurt; M. Apaydin; I. Akkol; Mihriban Heval Ozgen (Familial Cancer, 2013)

Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer - Bettina Meiser; Melanie A. Price; Phyllis N. Butow; Janan Karatas; Judy Wilson; Louise Heiniger; Brandi Baylock; Margaret Charles; Sue-Anne McLachlan; Kelly-Anne Phillips (Familial Cancer, 2013)

10 rare tumors that warrant a genetics referral - Kimberly C. Banks; Jessica J. Moline; Monica L. Marvin; Anna C. Newlin; Kristen J. Vogel (Familial Cancer, 2013)

Birt–Hogg–Dubé: beyond the clinical manifestations - Lindsay A. Middelton (Familial Cancer, 2013)

Multiple small “imaging” branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia? - D. K. Bartsch; K. Dietzel; M. Bargello; E. Matthaei; G. Kloeppel; I. Esposito; J. T. Heverhagen; T. M. Gress; E. P. Slater; P. Langer (Familial Cancer, 2013)

An unusual BRCA mutation distribution in a high risk cancer genetics clinic - Anna C. Nelson-Moseke; Joanne M. Jeter; Haiyan Cui; Denise J. Roe; Setsuko K. Chambers; Christina M. Laukaitis (Familial Cancer, 2013)

The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study - Sang-Ah Han; Sung-Won Kim; Eunyoung Kang; Sue K. Park; Sei-Hyun Ahn; Min Hyuk Lee; Seok-Jin Nam; Wonshik Han; Young Tae Bae; Hyun-Ah Kim; Young Up Cho; Myung Chul Chang; et al. (Familial Cancer, 2013)

The deletion of exons 3–5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families - Sarai Palanca; Inmaculada de Juan; Gema Perez-Simó; Eva Barragán; Isabel Chirivella; Eduardo Martínez; Óscar Fuster; Pascual Bolufer (Familial Cancer, 2013)

Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation - Ekatherina Sh. Kuligina; Anna P. Sokolenko; Nathalia V. Mitiushkina; Svetlana N. Abysheva; Elena V. Preobrazhenskaya; Tatiana V. Gorodnova; Grigoriy A. Yanus; Alexandr V. Togo; Nadezhda V. Cherdyntseva; Svetlana A. Bekhtereva; J. Michael Dixon; Alexey A. Larionov; et al. (Familial Cancer, 2013)

Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers - Elizabeth A. Schackmann; Diego F. Munoz; Meredith A. Mills; Sylvia K. Plevritis; Allison W. Kurian (Familial Cancer, 2013)

Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier - Shaheen Alanee; Sohela Shah; Rajmohan Murali; Rohini Rau-Murthy; Kasmintan A. Schrader; Kenneth Offit (Familial Cancer, 2013)

The spectrum of urological malignancy in Lynch syndrome - P. J. Barrow; S. Ingham; C. O’Hara; K. Green; I. McIntyre; F. Lalloo; J. Hill; D. G. Evans (Familial Cancer, 2013)

Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis - Y. A. Alderlieste; E. A. J. Rauws; E. M. H. Mathus-Vliegen; P. Fockens; E. Dekker (Familial Cancer, 2013)

Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study - Kate J. Lifford; Alison Clements; Lindsay Fraser; Deborah Lancastle; Kate Brain (Familial Cancer, 2013)

Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review - A. P. Knopperts; M. Nielsen; R. C. Niessen; C. M. J. Tops; B. Jorritsma; J. Varkevisser; J. Wijnen; C. L. E. Siezen; R. C. Heine-Bröring; H. J. van Kranen; Y. J. Vos; H. Westers; et al. (Familial Cancer, 2013)

Novel mutations of the APC gene and genetic consequences of splicing mutations in the Czech FAP families - Lucie Schwarzová; Jitka Štekrová; Martina Florianová; Aleš Novotný; Michaela Schneiderová; Petr Lněnička; Věra Kebrdlová; Jaroslav Kotlas; Kamila Veselá; Milada Kohoutová (Familial Cancer, 2013)

Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors - Isabelle Sourrouille; Florence Coulet; Jeremie H. Lefevre; Chrystelle Colas; Mélanie Eyries; Magali Svrcek; Armelle Bardier-Dupas; Yann Parc; Florent Soubrier (Familial Cancer, 2013)

The Fourth Birt–Hogg–Dubé Symposium, Cincinnati, USA, 28th–30th March, 2012 (Familial Cancer, 2013)

13th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC) (Familial Cancer, 2013)

Ovarian metastases of colorectal and duodenal cancer in familial adenomatous polyposis - Stijn Crobach; Tom van Wezel; Hans F. Vasen; Hans Morreau (Familial Cancer, 2012)

Familial breast cancer: less emotional distress in adult daughters if they provide emotional support to their affected mother - Andrea Vodermaier; Annette L. Stanton (Familial Cancer, 2012)

Low penetrance alleles as risk modifiers in familial and sporadic breast cancer - Eva Esteban Cardeñosa; Inmaculada de Juan Jiménez; Sarai Palanca Suela; Isabel Chirivella González; Ángel Segura Huerta; Ana Santaballa Beltran; María Casals El Busto; Eva Barragán González; Oscar Fuster Lluch; José Bermúdez Edo; Pascual Bolufer Gilabert (Familial Cancer, 2012)

Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act - Dawn C. Allain; Sue Friedman; Leigha Senter (Familial Cancer, 2012)

Is the controversy on breast cancer as part of the Lynch-related tumor spectrum still open? - Philippe Grandval; Emmanuelle Barouk-Simonet; Myriam Bronner; Marie-Pierre Buisine; Jessica Moretta; Julie Tinat; Sylviane Olschwang (Familial Cancer, 2012)

Multiple jejunal cancers resulting from combination of germline APC and MLH1 mutations - Noralane M. Lindor; Tom C. Smyrk; Sheila Buehler; Shanaka R. Gunawardena; Brittany C. Thomas; Paul Limburg; Salman Kirmani; Stephen N. Thibodeau (Familial Cancer, 2012)

Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer - Kimberly A. Zuhlke; Anna M. Johnson; Linda A. Okoth; Elena M. Stoffel; Christiane M. Robbins; Waibov A. Tembe; Claudia A. Salinas; S. Lilly Zheng; Jianfeng Xu; John D. Carpten; Ethan M. Lange; William B. Isaacs; et al. (Familial Cancer, 2012)

Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation - Christina Therkildsen; Anna Isinger-Ekstrand; Steen Ladelund; Anja Nissen; Eva Rambech; Inge Bernstein; Mef Nilbert (Familial Cancer, 2012)

Non-synonymous polymorphism (Gln261Arg) of 12-lipoxygenase in colorectal and thyroid cancers - Vidudala V. T. S. Prasad; Kolli Padma (Familial Cancer, 2012)

High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer - Pawel Gaj; Anna Kluska; Dorota Nowakowska; Aneta Bałabas; Magdalena Piątkowska; Michalina Dabrowska; Anna Niwińska; Jerzy Ostrowski (Familial Cancer, 2012)

No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways - Judith Penkert; Brigitte Schlegelberger; Doris Steinemann; Dorothea Gadzicki (Familial Cancer, 2012)

Routine TP53 testing for breast cancer under age 30: ready for prime time? - Jeanna M. McCuaig; Susan R. Armel; Ana Novokmet; Ophira M. Ginsburg; Rochelle Demsky; Steven A. Narod; David Malkin (Familial Cancer, 2012)

Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment - Laura Belvederesi; Francesca Bianchi; Cristian Loretelli; Raffaella Bracci; Stefano Cascinu; Riccardo Cellerino (Familial Cancer, 2012)

Novel mutations of OGG1 base excision repair pathway gene in laryngeal cancer patients - Ishrat Mahjabeen; Nosheen Masood; Ruqia Mehmood Baig; Maimoona Sabir; Uzma Inayat; Faraz Arshad Malik; Mahmood Akhtar Kayani (Familial Cancer, 2012)

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma - Stephanie Smetsers; Joanne Muter; Claire Bristow; Leena Patel; Kate Chandler; Denise Bonney; Robert F. Wynn; Anthony D. Whetton; Andrew M. Will; Davy Rockx; Hans Joenje; Gordon Strathdee; et al. (Familial Cancer, 2012)

Portuguese c.156_157insAlu BRCA2 founder mutation: gastrointestinal and tongue neoplasias may be part of the phenotype - Miguel A. M. Moreira; Irina G. Bobrovnitchaia; Maria Angélica F. D. Lima; Anna Cláudia E. Santos; Jesus P. Ramos; Kelly R. L. Souza; Ana Peixoto; Manuel R. Teixeira; Fernando R. Vargas (Familial Cancer, 2012)

Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation - Chihiro Kijima; Toshiyuki Miyashita; Maiko Suzuki; Hidehiro Oka; Kiyotaka Fujii (Familial Cancer, 2012)

Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas - K. J. Johnson; M. J. Fisher; R. L. Listernick; K. N. North; E. K. Schorry; D. Viskochil; M. Weinstein; J. B. Rubin; D. H. Gutmann (Familial Cancer, 2012)

Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome - Miguel Serrano; Pedro Lage; Sara Belga; Bruno Filipe; Inês Francisco; Paula Rodrigues; Ricardo Fonseca; Paula Chaves; Isabel Claro; Cristina Albuquerque; António Dias Pereira (Familial Cancer, 2012)

Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome - Masanobu Takahashi; Yoichi Furukawa; Hideki Shimodaira; Masato Sakayori; Takuya Moriya; Yoshihiro Moriya; Yusuke Nakamura; Chikashi Ishioka (Familial Cancer, 2012)

Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy? - Damian C. Balmforth; Robin K. S. Phillips; Susan K. Clark (Familial Cancer, 2012)

Hope-based intervention for individuals susceptible to colorectal cancer: a pilot study - Samuel Mun-yin Ho; Judy Wai-chu Ho; Barbara Ka-yan Pau; Bryant Pui-hung Hui; Rosa Sze-mun Wong; Annie Tsz-wai Chu (Familial Cancer, 2012)

Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome - Michael P. Farrell; David J. Hughes; Ian R. Berry; David J. Gallagher; Emily A. Glogowski; Stewart J. Payne; Michael J. Kennedy; Róisín M. Clarke; Susan A. White; Cian B. Muldoon; Fiona Macdonald; Pauline Rehal; et al. (Familial Cancer, 2012)

High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis - Rania Abdelmaksoud-Dammak; Imen Miladi-Abdennadher; Ali Amouri; Nabil Tahri; Lobna Ayadi; Abdelmajid Khabir; Foued Frikha; Ali Gargouri; Raja Mokdad-Gargouri (Familial Cancer, 2012)

Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma - Karin A. W. Wadt; Anne-Marie Gerdes; Thomas V. O. Hansen; Birgitte G. Toft; Lennart Friis-Hansen; Mette K. Andersen (Familial Cancer, 2012)

Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry - Mala Pande; Chongjuan Wei; Jinyun Chen; Christopher I. Amos; Patrick M. Lynch; Karen H. Lu; Laura A. Lucio; Stephanie G. Boyd-Rogers; Sarah A. Bannon; Maureen E. Mork; Marsha L. Frazier (Familial Cancer, 2012)

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome - Pascale This; Anne de la Rochefordière; Alexia Savignoni; Marie Christine Falcou; Anne Tardivon; Fabienne Thibault; Séverine Alran; Virgine Fourchotte; Alfred Fitoussi; Benoit Couturaud; Sylvie Dolbeault; Remy J. Salmon; et al. (Familial Cancer, 2012)

Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women - Darren Mays; McKane E. Sharff; Tiffani A. DeMarco; Bernice Williams; Beth Beck; Vanessa B. Sheppard; Beth N. Peshkin; Jennifer Eng-Wong; Kenneth P. Tercyak (Familial Cancer, 2012)

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families - Irene Catucci; Roni Milgrom; Anya Kushnir; Yael Laitman; Shani Paluch-Shimon; Sara Volorio; Filomena Ficarazzi; Loris Bernard; Paolo Radice; Eitan Friedman; Paolo Peterlongo (Familial Cancer, 2012)

Hepatoblastoma in two siblings and familial adenomatous polyposis: causal nexus or coincidence? - Christina Evers; Harald Gaspar; Matthias Kloor; Gergana Bozukova; Martina Kadmon; Monika Keller; Christian Sutter; Ute Moog (Familial Cancer, 2012)

Causes of death of mutation carriers in Finnish Lynch syndrome families - Kirsi Pylvänäinen; Tuula Lehtinen; Ilmo Kellokumpu; Heikki Järvinen; Jukka-Pekka Mecklin (Familial Cancer, 2012)

Closing the loop: an interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment - Deborah J. MacDonald; Julia Deri; Charité Ricker; Martin A. Perez; Raquel Ogaz; Nancy Feldman; Lori A. Viveros; Benjamin Paz; Jeffrey N. Weitzel; Kathleen R. Blazer (Familial Cancer, 2012)

Microsatellite instability testing in Korean patients with colorectal cancer - Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park (Familial Cancer, 2012)

The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis - Kui Zhang; Lushun Zhang; Xianmin Wang; Lin Zhang (Familial Cancer, 2012)

A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer - Natalie J. Engel; Patricia Gordon; Darcy L. Thull; Beth Dudley; Judy Herstine; Rachel C. Jankowitz; Kristin K. Zorn (Familial Cancer, 2012)

Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer - Silva Saarinen; Pia Vahteristo; Rainer Lehtonen; Kristiina Aittomäki; Virpi Launonen; Tuula Kiviluoto; Lauri A. Aaltonen (Familial Cancer, 2012)

Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations - Monique A. de Bruin; Ava Kwong; Benjamin A. Goldstein; Jafi A. Lipson; Debra M. Ikeda; Lisa McPherson; Bhavna Sharma; Ani Kardashian; Elizabeth Schackmann; Kerry E. Kingham; Meredith A. Mills; Dee W. West; et al. (Familial Cancer, 2012)

Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome - Giovanni Ponti; Lorenza Pastorino; Annamaria Pollio; Sabina Nasti; Giovanni Pellacani; Michele D. Mignogna; Aldo Tomasi; Corrado Del Forno; Caterina Longo; Giovanna Bianchi-Scarrà; Guido Ficarra; Stefania Seidenari (Familial Cancer, 2012)

French experts report on MUTYH-associated polyposis (MAP) - Bruno Buecher; Catherine Bonaïti; Marie-Pierre Buisine; Chrystelle Colas; Jean-Christophe Saurin (Familial Cancer, 2012)

Mutation screening of RAD51C in high-risk breast and ovarian cancer families - Wenping Lu; Xianshu Wang; Hongsheng Lin; Noralane M. Lindor; Fergus J. Couch (Familial Cancer, 2012)

Uroepithelial and kidney carcinoma in Lynch syndrome - Markku Aarnio; Matti Säily; Matti Juhola; Annette Gylling; Päivi Peltomäki; Heikki J. Järvinen; Jukka-Pekka Mecklin (Familial Cancer, 2012)

The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause - Carmel Pezaro; Paul James; Joanne McKinley; Mary Shanahan; Mary-Anne Young; Gillian Mitchell (Familial Cancer, 2012)

Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up - C. A. Jilg; Hartmut P. H. Neumann; S. Gläsker; O. Schäfer; C. Leiber; P. U. Ardelt; M. Schwardt; W. Schultze-Seemann (Familial Cancer, 2012)

The evolution of personalized cancer genetic counseling in the era of personalized medicine - Hetal S. Vig; Catharine Wang (Familial Cancer, 2012)

The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome - Ulla Platten; Johanna Rantala; Annika Lindblom; Yvonne Brandberg; Gunilla Lindgren; Brita Arver (Familial Cancer, 2012)

Adequacy of family history taking in ovarian cancer patients: a population-based study - Anne M. van Altena; Sandra van Aarle; Lambertus A. L. M. Kiemeney; Nicoline Hoogerbrugge; Leon F. A. G. Massuger; Joanne A. de Hullu (Familial Cancer, 2012)

Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance - Irma Kluijt; Rolf H. Sijmons; Nicoline Hoogerbrugge; John T. Plukker; Daphne de Jong; J. Han van Krieken; Richard van Hillegersberg; Marjolijn Ligtenberg; Eveline Bleiker; Anemieke Cats (Familial Cancer, 2012)

Q48P mutation in the hMLH1 gene associated with Lynch syndrome in three Hungarian families - Miklós Tanyi; Judit Olasz; Janos L. Tanyi; László Tóth; Péter Antal-Szalmás; Tamás Bubán; Csilla András; Hilda Urbancsek; Zoltán Garami; Orsolya Csuka; László Damjanovich (Familial Cancer, 2012)

Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes - Adam Andreasson; Luqman Sulaiman; Sónia do Vale; João Martin Martins; Florbela Ferreira; Gabriel Miltenberger-Miltenyi; Lucas Batista; Felix Haglund; Erik Björck; Inga-Lena Nilsson; Anders Höög; Catharina Larsson; et al. (Familial Cancer, 2012)

Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases - Izabela Brozek; Magdalena Ratajska; Magdalena Piatkowska; Anna Kluska; Aneta Balabas; Michalina Dabrowska; Dorota Nowakowska; Anna Niwinska; Jadwiga Rachtan; Jan Steffen; Janusz Limon (Familial Cancer, 2012)

Common MUTYH mutations and colorectal cancer risk in multiethnic populations - Flavio Lejbkowicz; Ilana Cohen; Ofra Barnett-Griness; Mila Pinchev; Jen Poynter; Stephen B. Gruber; Gad Rennert (Familial Cancer, 2012)

A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial - Maria W. J. van Vugt van Pinxteren; Mariëtte C. A. van Kouwen; Martijn G. H. van Oijen; Theo van Achterberg; Fokko M. Nagengast (Familial Cancer, 2012)

Families’ experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population - Álvaro Mendes; Liliana Sousa (Familial Cancer, 2012)

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing - C. Maheu; T. Apostolidis; A. Petri-Cal; E. Mouret-Fourme; M. Gauthier-Villars; C. Lasset; P. Berthet; J.-P. Fricker; O. Caron; E. Luporsi; L. Gladieff; C. Noguès; et al. (Familial Cancer, 2012)

Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore - Vivian Wei Wang; Poh Koon Koh; Wai Leng Chow; Jeremy Fung Yen Lim (Familial Cancer, 2012)

Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients - Muhammad U. Rashid; Sidra Gull; Kashif Asghar; Noor Muhammad; Asim Amin; Ute Hamann (Familial Cancer, 2012)

Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative - K. M. Landsbergen; J. B. Prins; H. G. Brunner; P. van Duijvendijk; F. M. Nagengast; J. H. van Krieken; M. Ligtenberg; N. Hoogerbrugge (Familial Cancer, 2012)

Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity? - Eli Brazowski; Paul Rozen; Sara Pel; Ziona Samuel; Irit Solar; Guy Rosner (Familial Cancer, 2012)

The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer - Yael Laitman; Liron Herskovitz; Talia Golan; Bella Kaufman; Shani Shimon Paluch; Eitan Friedman (Familial Cancer, 2012)

RB1 mutations and second primary malignancies after hereditary retinoblastoma - Charlotte J. Dommering; Tamara Marees; Annemarie H. van der Hout; Saskia M. Imhof; Hanne Meijers-Heijboer; Peter J. Ringens; Flora E. van Leeuwen; Annette C. Moll (Familial Cancer, 2012)

Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months - Jin Zhang; Jia-Hua Pan; Bai-Jun Dong; Wei Xue; Dong-ming Liu; Yi-Ran Huang (Familial Cancer, 2012)

Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening - Angela M. Cozzolino; Lucia Pedace; Marco Castori; Paola De Simone; Nicoletta Preziosi; Isabella Sperduti; Chiara Panetta; Valerio Mogini; Carmelilia De Bernardo; Aldo Morrone; Caterina Catricalà; Paola Grammatico (Familial Cancer, 2012)

Looking different, feeling different: women’s reactions to risk-reducing breast and ovarian surgery - Nina Hallowell; Brandi Baylock; Louise Heiniger; Phyllis N. Butow; Deepa Patel; Bettina Meiser; Christobel Saunders; Melanie A. Price (Familial Cancer, 2012)

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations - A. Moran; C. O’Hara; S. Khan; L. Shack; E. Woodward; E. R. Maher; F. Lalloo; D. G. R. Evans (Familial Cancer, 2012)

Hereditary medullary thyroid carcinoma: the management dilemma - Ping Zhou; Jian Liu; Shao-Wen Cheng; Bing Wang; Rong Yang; Ling Peng (Familial Cancer, 2012)

Preimplantation genetic diagnosis for inherited breast cancer: first clinical application and live birth in Spain - Teresa Ramón y Cajal; Ana Polo; Olga Martínez; Carles Giménez; César Arjona; Gemma Llort; Lluís Bassas; Pere Viscasillas; Joaquin Calaf (Familial Cancer, 2012)

Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families - S. M. Schneegans; A. Rosenberger; U. Engel; M. Sander; G. Emons; M. Shoukier (Familial Cancer, 2012)

Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands - Ruben Cremers; Christi van Asperen; Paul Kil; Hans Vasen; Tjerk Wiersma; Inge van Oort; Lambertus Kiemeney (Familial Cancer, 2012)

A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad - Ricardo Celestino; Jorge Lima; Alexandra Faustino; Valdemar Máximo; António Gouveia; João Vinagre; Paula Soares; José Manuel Lopes (Familial Cancer, 2012)

Management of duodenal adenomatosis in FAP: single centre experience - Musa Drini; Anthony Speer; Christopher Dow; Neil Collier; Prithi Bhathal; Finlay A. Macrae (Familial Cancer, 2012)

Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome - Victoria M. Raymond; Casey M. Herron; Thomas J. Giordano; Stephen B. Gruber (Familial Cancer, 2012)

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer - Anne Kinhult Ståhlbom; Hemming Johansson; Annelie Liljegren; Anna von Wachenfeldt; Brita Arver (Familial Cancer, 2012)

Increased incidence of childhood, prostate and breast cancers in relatives of childhood cancer patients - Susanne Magnusson; Thomas Wiebe; Ulf Kristoffersson; Helena Jernström; Håkan Olsson (Familial Cancer, 2012)

A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours - Lyn Schofield; Fabienne Grieu; Jack Goldblatt; Benhur Amanuel; Barry Iacopetta (Familial Cancer, 2012)

Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance - Karin Y. van Spaendonck-Zwarts; Sadhanna Badeloe; Sjoukje F. Oosting; Sjoerd Hovenga; Harry J. F. Semmelink; R. Jeroen A. van Moorselaar; Jan Hein van Waesberghe; Arjen R. Mensenkamp; Fred H. Menko (Familial Cancer, 2012)

Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors - Nils Rahner; Felix F. Brockschmidt; Verena Steinke; Philip Kahl; Tim Becker; Hans F. A. Vasen; Juul T. Wijnen; Carli J. M. Tops; Elke Holinski-Feder; Marjolijn J. L. Ligtenberg; Liesbeth Spruijt; Heike Görgens; et al. (Familial Cancer, 2012)

Self-reported mammography use following BRCA1/2 genetic testing may be overestimated - Geneviève Larouche; Karine Bouchard; Jocelyne Chiquette; Christine Desbiens; Jacques Simard; Michel Dorval (Familial Cancer, 2012)

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial - Pascal Pujol; Christine Lasset; Pascaline Berthet; Catherine Dugast; Suzette Delaloge; Jean-Pierre Fricker; Isabelle Tennevet; Nathalie Chabbert-Buffet; Pascale This; Karen Baudry; Jerome Lemonnier; Lise Roca; et al. (Familial Cancer, 2012)

Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma - X.-P. Qi; R.-B. Ying; J.-M. Ma; W.-T. Liu; Z.-F. Du; J. Fei; C.-P. Yang; Q.-Z. Song; H.-Y. Jin; Z.-G. Chen; J.-S. Han; J.-Q. Wang; et al. (Familial Cancer, 2012)

First degree relatives and familial aggregation of gastric cancer: who to choose for control in case–control studies? - Ricardo Marcos-Pinto; Mário Dinis-Ribeiro; Fátima Carneiro; José Carlos Machado; Ceu Figueiredo; Celso A. Reis; José Ferreira; Jorge Areias (Familial Cancer, 2012)

Patient outcomes associated with group and individual genetic counseling formats - Erin Rothwell; Wendy Kohlmann; Kory Jasperson; Amanda Gammon; Bob Wong; Anita Kinney (Familial Cancer, 2012)

Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London - Kelly Kohut; Lucia D’Mello; Elizabeth K. Bancroft; Sarah Thomas; Mary-Anne Young; Kathryn Myhill; Susan Shanley; Brian H. J. Briggs; Michelle Newman; Ifthikhar M. Saraf; Penny Cox; Sarah Scambler; et al. (Familial Cancer, 2012)

Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy - P. Ghiorzo; V. Pensotti; G. Fornarini; S. Sciallero; L. Battistuzzi; F. Belli; L. Bonelli; G. Borgonovo; W. Bruno; A. Gozza; S. Gargiulo; L. Mastracci; et al. (Familial Cancer, 2012)

BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients - Fatemeh Keshavarzi; Gholam Reza Javadi; Sirous Zeinali (Familial Cancer, 2012)

Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population - Inmaculada de Juan Jiménez; Eva Esteban Cardeñosa; Sarai Palanca Suela; Eva Barragán González; Ismael Aznar Carretero; Blanca Munárriz Gandía; Ana Santaballa Bertran; María Dolores Torregrosa Maicas; Carmen Guillén Ponce; Ana Beatriz Sánchez Heras; Ana Bayón Lara; Oscar Fuster Lluch; et al. (Familial Cancer, 2012)

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy - J. V. Cohen; L. Chiel; L. Boghossian; M. Jones; J. E. Stopfer; J. Powers; T. R. Rebbeck; K. L. Nathanson; S. M. Domchek (Familial Cancer, 2012)

Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients - Somayeh Shahmoradi; Ali Bidmeshkipour; Ahmad Salamian; Mohammad Hasan Emami; Zahra Kazemi; Mansoor Salehi (Familial Cancer, 2012)

A pre-visit tailored website enhances counselees’ realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling - Akke Albada; Sandra van Dulmen; Dick Lindhout; Jozien M. Bensing; Margreet G. E. M. Ausems (Familial Cancer, 2012)

The liver: another organ involved in Muir Torre syndrome? - F. Morando; M. Alaibac; A. Romano; M. Cavallin; S. Piano; M. Pizzi; C. Mescoli; P. Pilati; A. Gatta; P. Angeli (Familial Cancer, 2012)

Abstracts (Familial Cancer, 2011)

Familial colorectal cancer type X syndrome: two distinct molecular entities? - Inês Francisco; Cristina Albuquerque; Pedro Lage; Hélio Belo; Inês Vitoriano; Bruno Filipe; Isabel Claro; Sara Ferreira; Paula Rodrigues; Paula Chaves; Carlos Nobre Leitão; António Dias Pereira (Familial Cancer, 2011)

Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome? - Hugo Villeneuve; Steve Tremblay; Polymnia Galiatsatos; Nancy Hamel; Louis Guertin; Renald Morency; Marc Tischkowitz (Familial Cancer, 2011)

Microsatellite instability analysis in uterine cavity washings as a screening tool for endometrial cancer in Lynch syndrome - Julie Bouquier; Hélène Blons; Céline Narjoz; Fabrice Lécuru; Pierre Laurent-Puig; Anne-Sophie Bats (Familial Cancer, 2011)

A survey of APC mutations in Quebec - Jonathan Jarry; Jean-Sébastien Brunet; Rachel Laframboise; Régen Drouin; Jean Latreille; Carole Richard; Jean Gekas; Bruno Maranda; Yury Monczak; Nora Wong; Carly Pouchet; Sonya Zaor; et al. (Familial Cancer, 2011)

Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan - Muhammad U. Rashid; Sidra Gull; Saima Faisal; Saba Khaliq; Kashif Asghar; Neelam Siddiqui; Asim Amin; Ute Hamann (Familial Cancer, 2011)

Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors - Wai Kwan Siu; Chun Yiu Law; Ching Wan Lam; Chloe Miu Mak; Gary Wing Kin Wong; Andrew Yiu Yan Ho; Kwok Yip Ho; Ka Tai Loo; Sin Chuen Chiu; Louis Tsun Cheung Chow; Sui Fan Tong; Albert Yan Wo Chan (Familial Cancer, 2011)

Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A - Sarah M. Nielsen; Wendy S. Rubinstein; Darcy L. Thull; Michaele J. Armstrong; Eleanor Feingold; Linwah Yip; Samuel A. Tisherman; Sally E. Carty (Familial Cancer, 2011)

Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints - Noriko Ando; Yumi Iwamitsu; Masaru Kuranami; Shigemi Okazaki; Kenji Yamamoto; Masahiko Watanabe; Hitoshi Miyaoka (Familial Cancer, 2011)

Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment - Noriko Ishii; Masami Arai; Yurie Koyama; Masashi Ueno; Toshiharu Yamaguchi; Keiko Kazuma; Tetsuichiro Muto (Familial Cancer, 2011)

Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study - Helle Vendel Petersen; Mary Jane Esplen; Steen Ladelund; Inge Bernstein; Lone Sunde; Christina Carlsson; Mef Nilbert (Familial Cancer, 2011)

Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center - K. Ready; B. K. Arun; K. M. Schmeler; A. Uyei; J. K. Litton; K. H. Lu; C. C. Sun; S. K. Peterson (Familial Cancer, 2011)

The identification and management of hereditary diffuse gastric cancer in a large Jordanian family - Henry T. Lynch; Ibrahim Aldoss; Jane F. Lynch (Familial Cancer, 2011)

Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals - Mev Dominguez Valentin; Felipe Carneiro da Silva; Erika Maria Monteiro dos Santos; Bianca Garcia Lisboa; Ligia Petrolini de Oliveira; Fabio de Oliveira Ferreira; Israel Gomy; Wilson Toshihiko Nakagawa; Samuel Aguiar Junior; Mariana Redal; Carlos Vaccaro; Adriana Della Valle; et al. (Familial Cancer, 2011)

Introduction - Fred H. Menko (Familial Cancer, 2011)

A rationale for mTOR inhibitors as chemoprevention agents in Peutz-Jeghers syndrome - Scott K. Kuwada; Randall Burt (Familial Cancer, 2011)

LKB1 as the ghostwriter of crypt history - Marnix Jansen; Danielle Langeveld; Wendy W. J. De Leng; Anya N. A. Milne; Francis M. Giardiello; G. Johan A. Offerhaus (Familial Cancer, 2011)

Familial colorectal cancer: eleven years of data from a registry program in Switzerland - Michal Kovac; Endre Laczko; Ritva Haider; Josef Jiricny; Hansjakob Mueller; Karl Heinimann; Giancarlo Marra (Familial Cancer, 2011)

The LKB1 complex-AMPK pathway: the tree that hides the forest - Michaël Sebbagh; Sylviane Olschwang; Marie-Josée Santoni; Jean-Paul Borg (Familial Cancer, 2011)

Peutz-Jeghers syndrome: a patient’s view - Stephanie Sugars (Familial Cancer, 2011)

Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer - Xiaohong R. Yang; Lea Jessop; Timothy Myers; Laufey Amundadottir; Ruth M. Pfeiffer; William Wheeler; Kristen M. Pike; Jeff Yuenger; Laurie Burdett; Meredith Yeager; Stephen J. Chanock; Margaret A. Tucker; et al. (Familial Cancer, 2011)

Factors associated with an individuals’ decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved? - Anita Caruso; Cristina Vigna; Valentina Bigazzi; Carlo Leone; Gabriella Maggi; Aline Martayan; Fabio M. Sega; Francesco Cognetti; Antonella Savarese (Familial Cancer, 2011)

Cancer worry among Norwegian male BRCA1/2 mutation carriers - Nina Strømsvik; Målfrid Råheim; Eva Gjengedal (Familial Cancer, 2011)

Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer - Kathrin Bauer; Sara Michel; Miriam Reuschenbach; Nina Nelius; Magnus von Knebel Doeberitz; Matthias Kloor (Familial Cancer, 2011)

Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families - Angela Brieger; Knut Engels; Dieter Schaefer; Guido Plotz; Stefan Zeuzem; Jochen Raedle; Joerg Trojan (Familial Cancer, 2011)

A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Tunisian family with FAP - Imen Miladi-Abdennadher; Ali Amouri; Lobna Ayadi; Abdelmajid Khabir; Sameh Ellouze; Nabil Tahri; Mounir Frikha; Tahia Sellami-Boudawara; Raja Mokdad-Gargouri (Familial Cancer, 2011)

The sex ratio and age of onset features of gastric cancer patients in hereditary diffuse gastric cancer families - Junxiu Yu; Zhenfang Li (Familial Cancer, 2011)

Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch Syndrome - Akriti Dewanwala; Anu Chittenden; Margery Rosenblatt; Rowena Mercado; Judy E. Garber; Sapna Syngal; Elena M. Stoffel (Familial Cancer, 2011)

A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families - Kathleen Y. Yang; Aaron B. Caughey; Sarah E. Little; Michael K. Cheung; Lee-May Chen (Familial Cancer, 2011)

Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up? - C. Serrano; J. Alonso; G. Gómez-Mariano; E. Aguirre; O. Diez; N. Gadea; N. Bosch; J. Balmaña; B. Graña (Familial Cancer, 2011)

The differential diagnosis of familial lentiginosis syndromes - Maya B. Lodish; Constantine A. Stratakis (Familial Cancer, 2011)

LKB1 signaling in advancing cell differentiation - Lina Udd; Tomi P. Mäkelä (Familial Cancer, 2011)

The role of LKB1 in lung cancer - Montse Sanchez-Cespedes (Familial Cancer, 2011)

Gastrointestinal polyps and cancer in Peutz-Jeghers syndrome: clinical aspects - A. R. Latchford; R. K. S. Phillips (Familial Cancer, 2011)

Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results - Yoichi Iwamoto; Hideki Kanda; Koichiro Yamakado; Norihito Soga; Kiminobu Arima; Kan Takeda; Yoshiki Sugimura (Familial Cancer, 2011)

Case studies in the diagnosis and management of Peutz-Jeghers syndrome - Douglas Riegert-Johnson; Maegan Roberts; Ferga C. Gleeson; Murli Krishna; Lisa Boardman (Familial Cancer, 2011)

Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families - Patrizia Pasanisi; Eleonora Bruno; Elisabetta Venturelli; Siranoush Manoukian; Monica Barile; Bernard Peissel; Clelia De Giacomi; Bernardo Bonanni; Jacopo Berrino; Franco Berrino (Familial Cancer, 2011)

Familial breast cancer: is it time to move from a reactive to a proactive role? - H. Harris; I. Nippert; C. Julian-Reynier; J. Schmidtke; C. van Asperen; D. Gadzicki; A. Tibben; D. G. Evans (Familial Cancer, 2011)

A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance—functional analysis reveals the pathogenic one - Jukka Kantelinen; Thomas v. O. Hansen; Minttu Kansikas; Lotte Nylandsted Krogh; Mari K. Korhonen; Saara Ollila; Minna Nyström; Anne-Marie Gerdes; Reetta Kariola (Familial Cancer, 2011)

Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer - B. E. Kiely; M. L. Friedlander; R. L. Milne; L. Stanhope; P. Russell; M. A. Jenkins; P. Weideman; S. A. McLachlan; P. Grant; J. L. Hopper; K. A. Phillips (Familial Cancer, 2011)

Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technology - Elisabeth M. H. Mathus-Vliegen; Karam S. Boparai; Evelien Dekker; Nan van Geloven (Familial Cancer, 2011)

A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer - Ava Kwong; Enders K. O. Ng; Edmund Y. H. Tang; Chris L. P. Wong; Fian B. F. Law; Candy P. H. Leung; Aaron Chan; M. T. Cheung; M. Y. To; Edmond S. K. Ma; Dee W. West; James M. Ford (Familial Cancer, 2011)

Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics - Heli J. Lehtonen (Familial Cancer, 2011)

Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies - Karin Hardt; Sven Boris Heick; Beate Betz; Timm Goecke; Haniyeh Yazdanparast; Robin Küppers; Kati Servan; Verena Steinke; Nils Rahner; Monika Morak; Elke Holinski-Feder; Christoph Engel; et al. (Familial Cancer, 2011)

A new phenotypic manifestation of familial adenomatous polyposis - Daniel L. Edelstein; Francis M. Giardiello; Ali Basiri; Linda M. Hylind; Katharine Romans; Jennifer E. Axilbund; Marcia Cruz-Correa; Jessica C. Ramella-Roman (Familial Cancer, 2011)

BRCA1/2 genetic testing uptake and psychosocial outcomes in men - Kristi D. Graves; Rhoda Gatammah; Beth N. Peshkin; Ayelet Krieger; Christy Gell; Heiddis B. Valdimarsdottir; Marc D. Schwartz (Familial Cancer, 2011)

PALB2 mutations in familial breast and pancreatic cancer - Erin W. Hofstatter; Susan M. Domchek; Alexander Miron; Judy Garber; Molin Wang; Kathryn Componeschi; Leigh Boghossian; Penelope L. Miron; Katherine L. Nathanson; Nadine Tung (Familial Cancer, 2011)

Mutation deep within an intron of MSH2 causes Lynch syndrome - Mark Clendenning; Daniel D. Buchanan; Michael D. Walsh; Belinda Nagler; Christophe Rosty; Bryony Thompson; Amanda B. Spurdle; John L. Hopper; Mark A. Jenkins; Joanne P. Young (Familial Cancer, 2011)

Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study - Kui Huang; Lia P. Gutierrez; Steffen Bülow; Steven Gallinger; Antoni Castells; Craig J. Eagle; James M. Church (Familial Cancer, 2011)

Novel germline SDHD mutation: diagnosis and implications to the patient - Jeena Varghese; Montserrat Ayala-Ramirez; Thereasa Rich; Eric Rohren; Priya Rao; Camilo Jimenez (Familial Cancer, 2011)

Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study - Sook-Yee Yoon; Meow-Keong Thong; Nur Aishah Mohd Taib; Cheng-Har Yip; Soo-Hwang Teo (Familial Cancer, 2011)

Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations - Thomas v. O. Hansen; Lars Jønson; Ane Y. Steffensen; Mette K. Andersen; Susanne Kjaergaard; Anne-Marie Gerdes; Bent Ejlertsen; Finn C. Nielsen (Familial Cancer, 2011)

Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation - Patrizia Lastella; Margherita Patruno; Giovanna Forte; Alba Montanaro; Carmela Di Gregorio; Carlo Sabbà; Patrizia Suppressa; Adalgisa Piepoli; Anna Panza; Angelo Andriulli; Nicoletta Resta; Alessandro Stella (Familial Cancer, 2011)

A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges - Molly S. Daniels; Jennifer K. Burzawa; Amanda C. Brandt; Kathleen M. Schmeler; Karen H. Lu (Familial Cancer, 2011)

Impact of computer-assisted data collection, evaluation and management on the cancer genetic counselor’s time providing patient care - Stephanie A. Cohen; Dawn E. McIlvried (Familial Cancer, 2011)

Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome - V. Medina-Arana; L. Delgado; L. González; A. Bravo; H. Díaz; E. Salido; D. Riverol; J. J. González-Aguilera; A. M. Fernández-Peralta (Familial Cancer, 2011)

Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53 - Alessandra Ferrarini; Agnes Auteri-Kaczmarek; Alessia Pica; Nemya Boesch; Karl Heinimann; Stephan C. Schäfer; Sara Vesnaver-Megalo; Viviane Cina; Jacques S. Beckmann; Christian Monnerat (Familial Cancer, 2011)

German national case collection for familial pancreatic cancer (FaPaCa): ten years experience - Ralph Schneider; Emily P. Slater; Mercede Sina; Nils Habbe; Volker Fendrich; Elvira Matthäi; Peter Langer; Detlef K. Bartsch (Familial Cancer, 2011)

Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family - L. McKay; M. Frydenberg; L. Lipton; F. Norris; I. Winship (Familial Cancer, 2011)

Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma - Ingrid Slade; Anne Murray; Sandra Hanks; Ajith Kumar; Lisa Walker; Darren Hargrave; Jenny Douglas; Charles Stiller; Louise Izatt; Nazneen Rahman (Familial Cancer, 2011)

A new frameshift MEN1 gene mutation associated with familial malignant insulinomas - Shirin Hasani-Ranjbar; Mahsa M. Amoli; Azadeh Ebrahim-Habibi; Mohammad Hossein Gozashti; Nahid Khalili; Forugh A. Sayyahpour; Jila Hafeziyeh; Akbar Soltani; Bagher Larijani (Familial Cancer, 2011)

Familial gastric cancer: update for practice management - Giovanni Corso; Daniele Marrelli; Franco Roviello (Familial Cancer, 2011)

Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome) - Aedan Roberts; Derek Nancarrow; Mark Clendenning; Daniel D. Buchanan; Mark A. Jenkins; David Duggan; Darin Taverna; Diane McKeone; Rhiannon Walters; Michael D. Walsh; Bruce W. Young; Jeremy R. Jass; et al. (Familial Cancer, 2011)

Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma - N. Sabbaghian; R. Kyle; A. Hao; D. Hogg; M. Tischkowitz (Familial Cancer, 2011)

Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report - Matjaz Vogelsang; Radovan Komel (Familial Cancer, 2011)

The impact of cancer pathology confirmation on clinical management of a family history of cancer - E. Edwards; A. Lucassen (Familial Cancer, 2011)

Deranged Wnt signaling is frequent in hereditary nonpolyposis colorectal cancer - Anna Isinger-Ekstrand; Christina Therkildsen; Inge Bernstein; Mef Nilbert (Familial Cancer, 2011)

IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer - Maria Henningson; Maria Hietala; Therese Törngren; Håkan Olsson; Helena Jernström (Familial Cancer, 2011)

The impact of positive cancer family history on the clinical features and outcome of patients with non-small cell lung cancer - Ning Li; Kang Shao; Zhaoli Chen; Bin Qiu; Zhen Wang; Fengwei Tan; Jiwen Wang; Xiaogang Tan; Baozhong Li; Meihua Xiong; Fang Zhou; Jie He (Familial Cancer, 2011)

Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma - Erik F. Hensen; Jean-Pierre Bayley (Familial Cancer, 2011)

Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition - Mohamed H. Abdel-Rahman; Robert Pilarski; James B. Massengill; Benjamin B. Christopher; Frederick H. Davidorf (Familial Cancer, 2011)

The Third Birt-Hogg-Dubé Symposium, Maastricht, the Netherlands, May 11th and 12th, 2011 (Familial Cancer, 2011)

12th international meeting on psychosocial aspects of hereditary cancer (IMPAHC) (Familial Cancer, 2011)

4th Biennial Meeting: International Society for Gastrointestinal Hereditary Tumours (Familial Cancer, 2011)

Mutation analysis of the APC gene in unrelated Korean patients with FAP: four novel mutations with unusual phenotype - Sung-Hee Han; Jae-Song Ryu; Young-Jin Kim; Han-Ik Cho; Young-Ho Yang; Kyoung-Ryul Lee (Familial Cancer, 2011)

Two BRCA1/2 founder mutations in Jews of Sephardic origin - Michal Sagi; Avital Eilat; Liat Ben Avi; Yael Goldberg; Dani Bercovich; Tamar Hamburger; Tamar Peretz; Israela Lerer (Familial Cancer, 2011)

Gene expression in response to ionizing radiation and family history of gastric cancer - Francesca Marcon; Francesco Silvestrini; Ester Siniscalchi; Domenico Palli; Calogero Saieva; Riccardo Crebelli (Familial Cancer, 2011)

Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis - Aung Ko Win; John L. Hopper; Mark A. Jenkins (Familial Cancer, 2011)

Strictly defined familial male breast cancer - Uwe Güth; Dieter Müller; Dorothy Jane Huang; Ellen Obermann; Hansjakob Müller (Familial Cancer, 2011)

Care for patients with multiple endocrine neoplasia type 1: the current evidence base - C. R. C. Pieterman; M. R. Vriens; K. M. A. Dreijerink; R. B. van der Luijt; G. D. Valk (Familial Cancer, 2011)

Colorectal cancer: no longer the issue in familial adenomatous polyposis? - Daniel C. Gibbons; Ashish Sinha; Robin K. S. Phillips; Susan K. Clark (Familial Cancer, 2011)

An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models - Cheuk Wai Choi; Michael C. H. Lee; Wai Tong Ng; Lai Yau Law; Tsz Kok Yau; Anne W. M. Lee (Familial Cancer, 2011)

Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis - Ans M. W. van den Ouweland; Peter Elfferich; Roy Lamping; Raoul van de Graaf; Monique M. van Veghel-Plandsoen; S. M. Franken; A. C. Houweling (Familial Cancer, 2011)

Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor - Emilia M. Pinto; Raul C. Ribeiro; Gad B. Kletter; John P. Lawrence; Jesse J. Jenkins; Jinling Wang; Sheila Shurtleff; Lisa McGregor; Richard W. Kriwacki; Gerard P. Zambetti (Familial Cancer, 2011)

Genetic epidemiological analysis reveals a multi-gene additive model for gastric cancer - Sanyou Gao; Xiaohui Zhang; Peng Wang; Liping Dai; Jianying Zhang; Kaijuan Wang (Familial Cancer, 2011)

Cancer survivors: familial risk perception and management advice given to their relatives - Francois Eisinger; Anne Deborah Bouhnik; Laetitia Malavolti; Anne Gaelle Le Corroller-Soriano; Claire Julian-Reynier (Familial Cancer, 2011)

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations - Paboda Ratnayake; Claire E. Wakefield; Bettina Meiser; Graeme Suthers; Melanie A. Price; Jessica Duffy; Kathy Tucker (Familial Cancer, 2011)

A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history - Maurizio Pisanò; Valeria Mezzolla; Maria Maddalena Galante; Giovanni Alemanno; Corrado Manca; Vito Lorusso; Antonio Malvasi; Andrea Tinelli (Familial Cancer, 2011)

Hereditary prostate cancer as a feature of Lynch Syndrome - Christina M. Bauer; Anna M. Ray; Bronwen A. Halstead-Nussloch; Robert G. Dekker; Victoria M. Raymond; Stephen B. Gruber; Kathleen A. Cooney (Familial Cancer, 2011)

Sharing genetic risk with next generation: mutation-positive parents’ communication with their offspring in Lynch Syndrome - Katja I. Aktan-Collan; Helena A. Kääriäinen; Eeva M. Kolttola; Kirsi Pylvänäinen; Heikki J. Järvinen; Ari H. Haukkala; Jukka-Pekka Mecklin (Familial Cancer, 2011)

Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress - K. M. Landsbergen; J. B. Prins; H. G. Brunner; N. Hoogerbrugge (Familial Cancer, 2011)

A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives - Joël Vos; Fred Menko; Anna M. Jansen; Christi J. van Asperen; Anne M. Stiggelbout; Aad Tibben (Familial Cancer, 2011)